rotation.to
Following this device: dark.
Free account
rotation.to
Appearance
Following this device: dark.
Drag a card by its title · ⚙ to size, swap or remove

Who

Angela Walsh

Chief Financial Officer

Company insider

Files Form 4 as: Chief Financial Officer, Dogwood Therapeutics.

In numbers

Trades disclosed
12
Buys
2
Sells
0
Bought
$16K
Sold
$0
Companies
1
Companies where not an officer
0
First trade
21 Dec 2020
Last trade
5 Mar 2026
Last filed
6 Mar 2026

Companies traded

Where they are an officer
DWTX Dogwood TherapeuticsOfficer · Biotechnology · last 5 Mar 20262 buys · 0 sells

Activity over time

1 Nov 2024 – 1 Oct 2026
101Nov 24May 25Nov 25Apr 26Oct 26

Buys above the line, sells below, each month.

Every trade

TradedCompanyWhatAmount
5 Mar 2026filed 6 Mar 2026DWTX Dogwood Therapeuticsoption or derivative · BiotechnologySEC FORM 4 Code A—82,500 at $0.00filing
5 Mar 2026filed 6 Mar 2026DWTX Dogwood Therapeuticsoption or derivative · BiotechnologySEC FORM 4 Code A—82,500 at $0.00filing
4 Dec 2025filed 5 Dec 2025DWTX Dogwood Therapeuticsoption or derivative · BiotechnologySEC FORM 4 Code A—150,000 at $0.00filing
27 Jun 2025filed 1 Jul 2025DWTX Dogwood Therapeuticsoption or derivative · BiotechnologySEC FORM 4 Code A—12,075 at $0.00filing
26 Feb 2024filed 28 Feb 2024DWTX Dogwood Therapeuticsoption or derivative · BiotechnologySEC FORM 4 Code A—63,618 at $0.00filing
12 Dec 2022filed 14 Dec 2022DWTX Dogwood Therapeuticsoption or derivative · BiotechnologySEC FORM 4 Code A—80,000 at $0.00filing
23 Jun 2022filed 30 Jun 2022DWTX Dogwood Therapeuticsoption or derivative · BiotechnologySEC FORM 4 Code A—40,000 at $0.00filing
23 May 2022filed 24 May 2022DWTX Dogwood TherapeuticsBiotechnologySEC FORM 4 Bought$9,1602,000 at $4.58filing
21 Jun 2021filed 22 Jun 2021DWTX Dogwood Therapeuticsoption or derivative · BiotechnologySEC FORM 4 Code A—30,000 at $0.00filing
28 Jan 2021filed 1 Feb 2021DWTX Dogwood TherapeuticsBiotechnologySEC FORM 4 Bought$7,3001,000 at $7.30filing
11 Jan 2021filed 12 Jan 2021DWTX Dogwood Therapeuticsoption or derivative · BiotechnologySEC FORM 4 Code A—209 at $0.00filing
21 Dec 2020filed 21 Dec 2020DWTX Dogwood Therapeuticsoption or derivative · BiotechnologySEC FORM 4 Code A—41,412 at $0.00filing

News

Angela Walsh appointed Chair of Cork Airport Development Counciltravelextra.ie · 29 Sep 2026Dogwood Therapeutics, Inc (NASDAQ:DWTX) Sees Significant Drop in Short InterestDWTX · themarketsdaily.com · 14 Oct 2026

1 headline in the last 90 days name Angela Walsh; 1 article from the last 14 days about the 1 company they traded most, at most three about any one of them.

Sectors

Health Care2

Buys in green, sells in red, by the company’s sector.

Related people

John C. ThomasDirector · Director at Dogwood Therapeutics, filing Form 4 there in the last year
Richard James WhitleyDirector · Director at Dogwood Therapeutics, filing Form 4 there in the last year
Abel De La RosaDirector · Director at Dogwood Therapeutics, filing Form 4 there in the last year
David R. KeeferDirector · Director at Dogwood Therapeutics, filing Form 4 there in the last year
Ralph GrosswaldSVP of Operations · SVP of Operations at Dogwood Therapeutics, filing Form 4 there in the last year